Consolidated Statement Of Cash Flows

Kubota Pharmaceutical Holdings Co., Ltd. - Filing #7311615

Concept 2024-01-01 to
2024-06-30
As at
2024-06-30
2024-01-01 to
2024-06-30
2024-04-01 to
2024-06-30
2024-01-01 to
2024-06-30
As at
2023-12-31
2023-01-01 to
2023-06-30
As at
2023-06-30
2023-01-01 to
2023-06-30
2023-01-01 to
2023-06-30
2023-04-01 to
2023-06-30
As at
2022-12-31
Consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss)
-668,935,000 JPY
-668,935,000 JPY
-326,193,000 JPY
-668,935,000 JPY
-744,690,000 JPY
-744,690,000 JPY
-744,690,000 JPY
-300,356,000 JPY
Impairment losses (reversal of impairment losses)
5,590,000 JPY
JPY
Finance income
-4,392,000 JPY
-7,007,000 JPY
Finance costs
4,082,000 JPY
4,799,000 JPY
Subtotal
-691,763,000 JPY
-733,575,000 JPY
Interest paid
-4,047,000 JPY
-4,715,000 JPY
Net cash provided by (used in) operating activities
-695,810,000 JPY
-738,290,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-30,771,000 JPY
-13,665,000 JPY
Net cash provided by (used in) investing activities
-25,717,000 JPY
-6,499,000 JPY
Cash flows from financing activities
Net cash provided by (used in) financing activities
-11,141,000 JPY
85,794,000 JPY
Cash and cash equivalents
2,063,057,000 JPY
2,767,639,000 JPY
3,414,202,000 JPY
4,048,969,000 JPY
Effect of exchange rate changes on cash and cash equivalents
28,086,000 JPY
24,228,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.